Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Korean Journal of Hepato-Biliary-Pancreatic Surgery ; : 171-178, 2011.
Article in English | WPRIM | ID: wpr-38992

ABSTRACT

BACKGROUNDS/AIMS: Because of low incidence rates, there have been few reports on the patterns of and risk factors for recurrence after curative resection of the ampulla of Vater (AoV) cancer. The aim of this study was to characterize patterns of recurrence and to evaluate risk factors affecting survival rates and recurrence after curative resection. METHODS: Medical records of 181 patients who had undergone pancreaticoduodenectomy with curative intent for AoV adenocarcinoma between December 1994 and March 2010 at Samsung Medical Center were retrospectively reviewed. Factors influencing on overall survival rate, recurrence rates, and recurrence patterns were analyzed. RESULTS: Lymph node metastases and high preoperative serum carcinoembryonic antigen (CEA) level >5 ng/ml were identified as independent factors affecting overall survival (p=0.006, p5 ng/ml, and total bilirubin level >1.5 mg/dl were identified as independent prognostic factors of recurrence after curative resection (p=0.008, p<0.001, p=0.003, respectively). CONCLUSIONS: AoV adenocarcinoma has a better prognosis than other periampullary carcinomas, but still has a high recurrence rate, especially during the first three years after curative radical resection. Therefore, careful follow-up is needed during the first 3 years, especially for the higher risk group. Further study of adjuvant therapy to decrease recurrence after curative resection is now warranted.


Subject(s)
Humans , Adenocarcinoma , Ampulla of Vater , Bilirubin , Carcinoembryonic Antigen , Follow-Up Studies , Incidence , Lymph Nodes , Medical Records , Neoplasm Metastasis , Pancreaticoduodenectomy , Prognosis , Recurrence , Retrospective Studies , Risk Factors , Survival Rate
2.
Korean Journal of Hepato-Biliary-Pancreatic Surgery ; : 307-310, 2009.
Article in English | WPRIM | ID: wpr-140581

ABSTRACT

Somatostatinoma is a rare endocrine tumor that comprises around 1% of all gastroenteropancreatic endocrine neoplasm. The estimated annual incidence is 1 in 40 million. This tumor may be associated with von Recklinghausen's disease. We present here a rare case of a 51-year-old female patient with a duodenal nonfunctioning somatostatinoma combined with von Recklinghausen's disease. Whipple' procedure was performed. The postoperative course was uneventful and the histopathologic findings were consistent with malignant nonfunctioning somatostatinoma with lymph node metastases. The patient is alive, healthy and without tumor recurrence 10 months after surgery.


Subject(s)
Female , Humans , Middle Aged , Duodenum , Incidence , Lymph Nodes , Neoplasm Metastasis , Neuroendocrine Tumors , Neurofibromatosis 1 , Recurrence , Somatostatinoma
3.
Korean Journal of Hepato-Biliary-Pancreatic Surgery ; : 307-310, 2009.
Article in English | WPRIM | ID: wpr-140580

ABSTRACT

Somatostatinoma is a rare endocrine tumor that comprises around 1% of all gastroenteropancreatic endocrine neoplasm. The estimated annual incidence is 1 in 40 million. This tumor may be associated with von Recklinghausen's disease. We present here a rare case of a 51-year-old female patient with a duodenal nonfunctioning somatostatinoma combined with von Recklinghausen's disease. Whipple' procedure was performed. The postoperative course was uneventful and the histopathologic findings were consistent with malignant nonfunctioning somatostatinoma with lymph node metastases. The patient is alive, healthy and without tumor recurrence 10 months after surgery.


Subject(s)
Female , Humans , Middle Aged , Duodenum , Incidence , Lymph Nodes , Neoplasm Metastasis , Neuroendocrine Tumors , Neurofibromatosis 1 , Recurrence , Somatostatinoma
SELECTION OF CITATIONS
SEARCH DETAIL